BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8470917)

  • 21. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
    Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
    Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
    Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
    Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
    Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
    Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
    Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].
    Iwamoto S; Kimoto M; Mure T; Onuma E; Yamamoto Y; Iki K; Yoshida K; Tadaoka Y; Majima T; Kawasaki S; Kubozoe T; Tsunoda T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):541-6. PubMed ID: 9530360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
    Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
    Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of gastric cancer completely responding to sequential methotrexate and 5-fluorouracil therapy].
    Ono M; Ishikawa H; Suzuki N; Miura T; Kaga S; Kano A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2035-8. PubMed ID: 8085854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [FOLFIRI regimen for metastatic or recurrent colorectal cancer].
    Uemura N; Yamada Y
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):904-6. PubMed ID: 16835477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ; Madajewicz S; Herrera L; Rustum YM; Trave F; Creaven P; Mittelman A
    NCI Monogr; 1987; (5):189-92. PubMed ID: 3501541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential 5-fluorouracil and methotrexate. Negative experience in metastatic colorectal cancer.
    Wanderås EH; Fosså SD; Tveit KM; Flokkmann A
    Acta Oncol; 1987; 26(4):289-93. PubMed ID: 3500730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer].
    Okabo S; Arai T; Maruyama S; Lee M; Murase N; Tsubaki M; Endo M; Wada Y; Shimoju K; Sakurazawa K; Sugihara K; Maruyama M; Yabata E; Kawasaki T; Sasaki T
    Gan To Kagaku Ryoho; 1997 May; 24(7):849-54. PubMed ID: 9170524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma].
    Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intra-aortic infusion therapy with sequential methotrexate (MTX) and 5-FU in advanced gastric carcinoma].
    Kitamura M; Awane Y; Konishi T; Suzuki T; Arai K; Kosaki G; Sasaki T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1927-33. PubMed ID: 3486635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.